大脑磁共振成像检查表明,儿童时期未被识别的低血糖症
Chris Worth1, Pon Ramya Gokul1, Katie Ramsden1
1Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, United Kingdom.
Frontiers in endocrinology
|April 15, 2024
概括
未被识别的早期低血糖症可能导致脑损伤,可通过MRI检测. 这项研究发现了儿童缺失低血糖事件的证据,强调需要提高意识,以防止神经损伤.
科学领域:
- 儿科神经学 儿科神经学
- 神经辐射学神经辐射学
- 新生儿医学 新生儿医学
背景情况:
- 新生儿和生命早期低血糖是常见的,但往往无症状,复杂的诊断.
- 低血糖会导致大脑损伤,由白质和大脑后部区域的特定MRI发现证明.
- 儿童中未被识别的早期低血糖症引起的大脑损伤的发生程度尚不清楚.
研究的目的:
- 为了调查儿童中未被识别的早期低血糖事件导致的脑损伤的存在.
- 为了检查回顾性神经成像发现的证据,以证明过去错过的低血糖事件.
主要方法:
- 从一个单一的三级医疗中心10年来MRI报告的回顾性审查.
- 搜索了"低血糖症"的电子放射学存储库,并审查了相关的图像和报告.
- 评估医疗记录以确定在成像之前是否诊断出低血糖症.
主要成果:
- 审查了107份MRI报告;52份 (48.5%) 显示出暗示低血糖脑损伤的特征.
- 在这些病例中,有22例 (42%) 的病历没有先前的低血糖诊断,这表明了潜在的错过事件.
- 研究结果表明,高血糖性脑损伤的很大一部分可能源于未被识别的早期生活事件.
结论:
- 这项研究证实了未被识别的儿童低血糖导致脑损伤的存在,通过神经影像识别.
- 强调急需提高对早期低血糖的临床意识.
- 强调主动识别和管理,以防止儿童长期出现不良的神经结果.
相关概念视频
Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...


